3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow thienopyridine: new trials by email Literature Review of thienopyridine trials Research Report on thienopyridine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK) PROMUS Element Everolimus-Eluting Coronary Stent System, Aspirin, Thienopyridine - Coronary Artery Disease | Phase 3 | Completed | Boston Scientific Corporation | 22 | 2009-10-01 | 2019-03-26 |
| The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL) PROMUS Element Coronary Stent System, Aspirin, Thienopyridine - Coronary Artery Disease | Phase 3 | Completed | Boston Scientific Corporation | 102 | 2009-02-01 | 2019-03-26 |
| The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions PROMUS Coronary Stent System, PROMUS Element Coronary Stent System, Aspirin - Coronary Artery Disease | Phase 3 | Completed | Boston Scientific Corporation | 1530 | 2009-01-01 | 2019-03-27 |
Boston Scientific Corporation (3)
Japan (3) · United States (3) · Australia (2) · Belgium (2) · France (2) · Latvia (2) · New Zealand (2) · Austria (1) · Denmark (1) · Finland (1) · Germany (1) · Malaysia (1) · Netherlands (1) · Poland (1) · Portugal (1)
Peter M. Maurer, MPH (2) · Peter M Maurer, MPH (1)